Topic

Bengaluru stocks

1 article

Syngene International Reports Modest 3% FY26 Revenue Growth Amid Biologics Headwinds
News 30 Apr 2026

Syngene International Reports Modest 3% FY26 Revenue Growth Amid Biologics Headwinds

Q4 Revenue Rises 2% YoY to ₹1,037 Cr; Operating EBITDA Margin at 25% for Full Year Syngene International Limited, a…